http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3754283-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb4ee28d43b5e8d4a3c5141fa9bcfeb0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F24F13-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F28F2265-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F28F2245-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F28F2245-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F28F19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F28F13-182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F28F13-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F28F13-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F24F13-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F28F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-00
filingDate 2019-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08265661f1529a2c5dddb357a2b92d74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e9acfdbfce5f434be3bcd243e5051ed
publicationDate 2020-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3754283-A1
titleOfInvention Drug-containing capsule, and component for air treatment device
abstract A drug-containing capsule (20, 30, 40) includes a capsule material (21, 31, 41) and a drug (22, 32, 42) disposed within the capsule material (21, 31, 41) and having a sterilization action for a specific microorganism. The capsule material (21, 31, 41) includes a degradable part (21a, 31a, 41a) formed of a raw material that is caused to biodegrade by the specific microorganism. This results in suppression of release of the drug while the specific microorganism does not proliferate.
priorityDate 2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227400098
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227400097
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87207368
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1280
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4932

Total number of triples: 42.